It's a risk for those thinking to sell now. IR Med could have FDA approval at any point in time during the course of H1 2024. Once that happens, I believe we will see that distribution contract filled out with PI Prevention Care LLC and we will see that it is most likely one of our subs. I still expect the RM first as we must be at a much higher PPS before announcing such deals. Telehealth and Cannabis are lined up as well I am sure

Investors Hangout: https://investorshangout.com/post/view?id=667...z8SZs9q6Aj

This CLOWN has been posting do not sell it would be a mistake since .165

IR Med is overpriced as a company & is due for a big fall once volume hits it.